微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 47.18% | -6.93% | 3.89% | 80/139 | 51.97% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 45.41% | -18.81% | -8.78% | 82/139 | 51.43% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 49.78% | -21.67% | -3.7% | 74/139 | 51.66% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 51.69% | -19.74% | 1.98% | 74/139 | 51.8% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 50.69% | -12.46% | -9.37% | 69/139 | 51.48% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 55.93% | -13.46% | -12% | 63/139 | 52.35% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 63.55% | -10.26% | -1.33% | 51/139 | 53.23% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 64.41% | -8% | 11.24% | 46/139 | 53.35% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 57.9% | -17.71% | -10.4% | 60/139 | 53.36% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 64.62% | -7.56% | -8.75% | 43/139 | 53.18% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 70.82% | -4.25% | 1.16% | 23/139 | 54.03% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 70.01% | -2.86% | -0.5% | 27/139 | 53.47% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 70.36% | -5.36% | 0.65% | 25/139 | 53.71% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 69.91% | -3.36% | -5.48% | 26/139 | 53.71% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 73.96% | 2% | 2.63% | 20/139 | 55.18% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 72.06% | 2% | -0.37% | 24/139 | 54.84% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 72.34% | -6.26% | -2.7% | 29/139 | 57.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-03-31 | 74.35% | 2% | -3.66% | 24/139 | 60.69% | 三友医疗 | 90.5% | 行业排名> |
| 2020-12-31 | 77.17% | 14.02% | 14.02% | 23/139 | 59.49% | 三友医疗 | 90.29% | 行业排名> |
| 2019-12-31 | 67.68% | 0.7% | 0.7% | 42/139 | 56.29% | 正海生物 | 90.78% | 行业排名> |
| 2018-12-31 | 67.21% | 2% | 2% | 38/139 | 55.53% | 正海生物 | 91.59% | 行业排名> |